Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Pharmacogenomics: current status and future perspectives
2023 Standout
Associations between Per- and Polyfluoroalkyl Substances Exposures and Blood Lipid Levels among Adults—A Meta-Analysis
2023 Standout
Works of Armando Lira being referenced
Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context
2017
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Armando Lira | 258 | 81 | 92 | 7 | 321 | |
| Andrew Friedman | 248 | 76 | 85 | 8 | 346 | |
| Stephen Jones | 245 | 79 | 58 | 11 | 355 | |
| Joseph Rubino | 182 | 68 | 76 | 6 | 283 | |
| Faisal Majeed | 170 | 61 | 45 | 7 | 276 | |
| Laurien E. Zijlstra | 223 | 119 | 43 | 11 | 317 | |
| Pascal Pfister | 221 | 45 | 42 | 12 | 350 | |
| Malcolm Kendrick | 181 | 65 | 63 | 9 | 360 | |
| Suzanne Lind | 229 | 109 | 24 | 10 | 327 | |
| Geraldine Macdonell | 276 | 50 | 50 | 7 | 334 | |
| Evan Stein | 264 | 60 | 75 | 6 | 316 |
All Works
Loading papers...